
Colleen Erin Snow
Examiner (ID: 14817, Phone: (571)272-8603 , Office: P/2899 )
| Most Active Art Unit | 2899 |
| Art Unit(s) | 2813, 2899 |
| Total Applications | 852 |
| Issued Applications | 644 |
| Pending Applications | 44 |
| Abandoned Applications | 177 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18151984
[patent_doc_number] => 11564933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Methods of treating testosterone deficiency
[patent_app_type] => utility
[patent_app_number] => 16/382835
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8068
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382835
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382835 | Methods of treating testosterone deficiency | Apr 11, 2019 | Issued |
Array
(
[id] => 15604205
[patent_doc_number] => 10583143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Methods and compositions for the treatment or prevention of abnormal bone formation in a soft tissue
[patent_app_type] => utility
[patent_app_number] => 16/380525
[patent_app_country] => US
[patent_app_date] => 2019-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 13972
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16380525
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/380525 | Methods and compositions for the treatment or prevention of abnormal bone formation in a soft tissue | Apr 9, 2019 | Issued |
Array
(
[id] => 14621913
[patent_doc_number] => 20190224324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 16/373014
[patent_app_country] => US
[patent_app_date] => 2019-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16373014
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/373014 | Compositions for the treatment of gastrointestinal inflammation | Apr 1, 2019 | Issued |
Array
(
[id] => 16569075
[patent_doc_number] => 20210008081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => ORAL LIQUID FORMULATIONS OF ABIRATERONE
[patent_app_type] => utility
[patent_app_number] => 17/042351
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17042351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/042351 | ORAL LIQUID FORMULATIONS OF ABIRATERONE | Mar 27, 2019 | Abandoned |
Array
(
[id] => 14960595
[patent_doc_number] => 20190307775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => 17-Hydroxyprogesterone Ester-Containing Oral Compositions and Related Methods
[patent_app_type] => utility
[patent_app_number] => 16/368431
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16368431
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/368431 | 17-hydroxyprogesterone ester-containing oral compositions and related methods | Mar 27, 2019 | Issued |
Array
(
[id] => 14578449
[patent_doc_number] => 20190216833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => NERIDRONIC ACID AND OTHER BISPHOSPHONATES FOR TREATING COMPLEX REGIONAL PAIN SYNDROME AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/366818
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16366818
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/366818 | Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases | Mar 26, 2019 | Issued |
Array
(
[id] => 16288865
[patent_doc_number] => 10765687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Methods and compounds to inhibit enveloped virus release
[patent_app_type] => utility
[patent_app_number] => 16/361556
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12934
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16361556
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/361556 | Methods and compounds to inhibit enveloped virus release | Mar 21, 2019 | Issued |
Array
(
[id] => 16822611
[patent_doc_number] => 20210137904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => FORMULATION
[patent_app_type] => utility
[patent_app_number] => 16/982883
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6766
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982883
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/982883 | Formulation | Mar 21, 2019 | Issued |
Array
(
[id] => 16405366
[patent_doc_number] => 10813902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-27
[patent_title] => DOPA decarboxylase inhibitor compositions
[patent_app_type] => utility
[patent_app_number] => 16/353544
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13152
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/353544 | DOPA decarboxylase inhibitor compositions | Mar 13, 2019 | Issued |
Array
(
[id] => 17280809
[patent_doc_number] => 11197822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
[patent_app_type] => utility
[patent_app_number] => 16/299058
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19388
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299058
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/299058 | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract | Mar 10, 2019 | Issued |
Array
(
[id] => 15454219
[patent_doc_number] => 20200039934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => CRYSTALLINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/298179
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298179
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/298179 | Crystalline compounds | Mar 10, 2019 | Issued |
Array
(
[id] => 16655957
[patent_doc_number] => 20210052593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => Compositions and Methods for the Treatment of Macrophage Activation Syndrome
[patent_app_type] => utility
[patent_app_number] => 16/977874
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977874
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977874 | Compositions and Methods for the Treatment of Macrophage Activation Syndrome | Mar 7, 2019 | Abandoned |
Array
(
[id] => 15451175
[patent_doc_number] => 20200038411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => METHODS OF TREATING TESTOSTERONE DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 16/295427
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16295427
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/295427 | METHODS OF TREATING TESTOSTERONE DEFICIENCY | Mar 6, 2019 | Abandoned |
Array
(
[id] => 16655962
[patent_doc_number] => 20210052598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/977375
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977375
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977375 | COMPOSITIONS AND METHODS FOR TREATING CANCER | Mar 5, 2019 | Abandoned |
Array
(
[id] => 15912907
[patent_doc_number] => 10653675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry
[patent_app_type] => utility
[patent_app_number] => 16/293024
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7845
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16293024
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/293024 | Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry | Mar 4, 2019 | Issued |
Array
(
[id] => 14578283
[patent_doc_number] => 20190216750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => EPINEPHRINE SPRAY FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/290853
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16290853
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/290853 | Epinephrine spray formulations | Feb 28, 2019 | Issued |
Array
(
[id] => 15175119
[patent_doc_number] => 20190358151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => TOPICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/287779
[patent_app_country] => US
[patent_app_date] => 2019-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16287779
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/287779 | Topical composition | Feb 26, 2019 | Issued |
Array
(
[id] => 15129941
[patent_doc_number] => 10478407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-19
[patent_title] => Pharmaceutical composition for viral infections
[patent_app_type] => utility
[patent_app_number] => 16/283683
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 26
[patent_no_of_words] => 44868
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283683
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/283683 | Pharmaceutical composition for viral infections | Feb 21, 2019 | Issued |
Array
(
[id] => 17256750
[patent_doc_number] => 20210369735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => PHYTOECDYSONES FOR USE IN THE PREVENTION OF MUSCLE STRENGTH LOSS DURING IMMOBILISATION
[patent_app_type] => utility
[patent_app_number] => 16/976189
[patent_app_country] => US
[patent_app_date] => 2019-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976189
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/976189 | PHYTOECDYSONES FOR USE IN THE PREVENTION OF MUSCLE STRENGTH LOSS DURING IMMOBILISATION | Feb 19, 2019 | Abandoned |
Array
(
[id] => 14682151
[patent_doc_number] => 20190240190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => NON-HORMONAL TREATMENT OF THE GENITOURINARY SYNDROME OF MENOPAUSE
[patent_app_type] => utility
[patent_app_number] => 16/269719
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269719
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/269719 | Non-hormonal treatment of the genitourinary syndrome of menopause | Feb 6, 2019 | Issued |